Akebia Therapeutics (AKBA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -384,841 | -296,457 | -236,498 | -60,747 | -279,659 |
| Depreciation Amortization | 149,070 | 141,362 | 134,771 | 9,625 | 37,827 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | -6,631 |
| Accounts receivable | 11,669 | 14,398 | -251 | -66,008 | -22,198 |
| Other Working Capital | -12,855 | -11,252 | -14,529 | -54,582 | -99,069 |
| Other Operating Activity | 126,569 | 72,343 | 64,138 | 82,123 | 112,289 |
| Operating Cash Flow | $-110,388 | $-79,606 | $-52,369 | $-89,589 | $-257,441 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 60,245 | 245 | 245 | 245 | 153,110 |
| PPE Investments | -317 | N/A | -45 | N/A | -6,655 |
| Purchase Of Investment | -99,932 | -99,932 | -49,950 | N/A | N/A |
| Sale Of Investment | 60,245 | N/A | N/A | N/A | 64,721 |
| Other Investing Activity | -60,245 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-40,004 | $-99,687 | $-49,750 | $245 | $211,176 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 19,975 | N/A | N/A | N/A | 77,668 |
| Debt Repayment | N/A | N/A | N/A | N/A | -15,000 |
| Common Stock Issued | 211,745 | 201,209 | 200,155 | 57,348 | 26,728 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -426 |
| Financing Cash Flow | $231,720 | $201,209 | $200,155 | $57,348 | $88,970 |
| Beginning Cash Position | 149,804 | 149,804 | 149,804 | 149,804 | 107,099 |
| End Cash Position | 231,132 | 171,720 | 247,840 | 117,808 | 149,804 |
| Net Cash Flow | $81,328 | $21,916 | $98,036 | $-31,996 | $42,705 |
| Free Cash Flow | |||||
| Operating Cash Flow | -110,388 | -79,606 | -52,369 | -89,589 | -257,441 |
| Capital Expenditure | -317 | 0 | -45 | 0 | -6,655 |
| Free Cash Flow | -110,705 | -79,606 | -52,414 | -89,589 | -264,096 |